Trials / Completed
CompletedNCT02857231
Bioimpedance Spectroscopy Compared to CardioMEMS™
Bioimpedance Spectroscopy Compared to CardioMEMS™ Determined Pulmonary Artery Pressure Measurements
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- ImpediMed Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.
Detailed description
This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll ten participants from the Scripps Clinic. Participants will be monitored 3 times a week for a period of 4 weeks. At each monitoring visit, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the ImpediMed's BIS technology. Participant's vital signs and weight will also be taken at each monitoring visit.
Conditions
Timeline
- Start date
- 2017-08-07
- Primary completion
- 2018-03-19
- Completion
- 2018-10-09
- First posted
- 2016-08-05
- Last updated
- 2019-07-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02857231. Inclusion in this directory is not an endorsement.